157 related articles for article (PubMed ID: 8882748)
1. Estimation of population pharmacokinetics using the Gibbs sampler.
Best NG; Tan KK; Gilks WR; Spiegelhalter DJ
J Pharmacokinet Biopharm; 1995 Aug; 23(4):407-35. PubMed ID: 8882748
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
3. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
4. Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic Models.
Duong A; Marsot A
Clin Pharmacol Drug Dev; 2024 Jul; 13(7):739-747. PubMed ID: 38465725
[TBL] [Abstract][Full Text] [Related]
5. Thoughts on "Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates".
de Hoog M; Mouton JW; van den Anker JN
Ther Drug Monit; 2003 Apr; 25(2):256-7; author reply 257. PubMed ID: 12657925
[No Abstract] [Full Text] [Related]
6. Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model.
Jensen PD; Edgren BE; Brundage RC
Pharmacotherapy; 1992; 12(3):178-82. PubMed ID: 1608849
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Modeling of Gentamicin in Pediatrics.
Wang H; Sherwin C; Gobburu JVS; Ivaturi V
J Clin Pharmacol; 2019 Dec; 59(12):1584-1596. PubMed ID: 31286535
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.
Germovsek E; Kent A; Metsvaht T; Lutsar I; Klein N; Turner MA; Sharland M; Nielsen EI; Heath PT; Standing JF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4869-77. PubMed ID: 27270281
[TBL] [Abstract][Full Text] [Related]
10. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
[TBL] [Abstract][Full Text] [Related]
11. The influence of assay error weight on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients.
Burm JP
Arch Pharm Res; 2005 May; 28(5):598-603. PubMed ID: 15974449
[TBL] [Abstract][Full Text] [Related]
12. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Vercaigne LM; Ariano RE; Zacharias JM
Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
[TBL] [Abstract][Full Text] [Related]
15. The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients.
Burm JP
Biopharm Drug Dispos; 2005 Jul; 26(5):189-94. PubMed ID: 15906419
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of gentamicin in South African newborns.
Botha JH; du Preez MJ; Adhikari M
Eur J Clin Pharmacol; 2003 Dec; 59(10):755-9. PubMed ID: 14566440
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of gentamicin in horses.
Martín-Jiménez T; Papich MG; Riviere JE
Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412
[TBL] [Abstract][Full Text] [Related]
18. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
Jordan P; Brunschwig H; Luedin E
Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of gentamicin and dosing optimization for infants.
Medellín-Garibay SE; Rueda-Naharro A; Peña-Cabia S; García B; Romano-Moreno S; Barcia E
Antimicrob Agents Chemother; 2015 Jan; 59(1):482-9. PubMed ID: 25385111
[TBL] [Abstract][Full Text] [Related]
20. Analysis of population pharmacokinetic data using NONMEM and WinBUGS.
Duffull SB; Kirkpatrick CM; Green B; Holford NH
J Biopharm Stat; 2005; 15(1):53-73. PubMed ID: 15702605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
